The Mystery of Coronary Artery Spasm

Heart Lung and Circulation

Volumn 16, Issue 1, 2007, Pages 10-15

  Ajani, Andrew E ^a,b   Yan, Bryan P ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Coronary spasm; Endothelial dysfunction; Oxidative stress; Vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOMETRINE; ERGOT ALKALOID; FASUDIL; HISTAMINE; HLA DR2 ANTIGEN; MAGNESIUM; NIFEDIPINE; NITRATE; NITRIC OXIDE SYNTHASE; PRAZOSIN; PROPRANOLOL; RHO KINASE INHIBITOR; SEROTONIN; VERAPAMIL;

ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; BLOOD VESSEL TONE; CAUCASIAN; CHURG STRAUSS SYNDROME; CLINICAL TRIAL; COCAINE DEPENDENCE; CORONARY ARTERY; CORONARY ARTERY SPASM; CORONARY STENT; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; EPICARDIUM; GENETIC SUSCEPTIBILITY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERVENTILATION; JAPANESE; MIGRAINE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; RACE DIFFERENCE; RAYNAUD PHENOMENON; REVIEW; SIDE EFFECT; SMOKING CESSATION; SMOOTH MUSCLE CONTRACTION; ST SEGMENT ELEVATION; STIMULUS RESPONSE; SYMPATHECTOMY; SYSTEMIC VASCULITIS; TREATMENT FAILURE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

CORONARY VASOSPASM; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PROGNOSIS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 33846443994     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2006.11.003     Document Type: Review

References (81)

1. Prinzmetal M., Kennamer R., Merliss R., Wada T., and Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 27 (1959) 375-388
2. Konidala S., and Gutterman D.D. Coronary vasospasm and the regulation of coronary blood flow. Prog Cardiovasc Dis 46 4 (2004) 349-373
3. Bertrand M.E., LaBlanche J.M., Tilmant P.Y., Thieuleux F.A., Delforge M.R., Carre A.G., et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 65 7 (1982) 1299-1306
4. Reddy K.G., Nair R.N., Sheehan H.M., and Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 23 4 (1994) 833-843
5. Kugiyama K., Yasue H., Okumura K., Ogawa H., Fujimoto K., Nakao K., et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94 3 (1996) 266-271
6. Sugiishi M., and Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 87 1 (1993) 76-79
7. Ogawa H., Yasue H., Oshima S., Okumura K., Matsuyama K., and Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 80 6 (1989) 1617-1626
8. Previtali M., Ardissino D., Barberis P., Panciroli C., Chimienti M., and Salerno J.A. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol 63 1 (1989) 17-20
9. Fuller C.M., Raizner A.E., Chahine R.A., Nahormek P., Ishimori T., Verani M., et al. Exercise-induced coronary arterial spasm: angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention. Am J Cardiol 46 3 (1980) 500-506
10. Miwa K., Kambara H., Kawai C., and Murakami T. Two electrocardiographic patterns with or without transient T-wave inversion during recovery periods of variant anginal attacks. Jpn Circ J 47 12 (1983) 1415-1422
11. Previtali M., Klersy C., Salerno J.A., Chimienti M., Panciroli C., Marangoni E., et al. Ventricular tachyarrhythmias in Prinzmetal's variant angina: clinical significance and relation to the degree and time course of S-T segment elevation. Am J Cardiol 52 1 (1983) 19-25
12. Miller D.D., Waters D.D., Szlachcic J., and Theroux P. Clinical characteristics associated with sudden death in patients with variant angina. Circulation 66 3 (1982) 588-592
13. Suzuki M., Nishizaki M., Arita M., Ashikaga T., Yamawake N., Kakuta T., et al. Increased QT dispersion in patients with vasospastic angina. Circulation 98 5 (1998) 435-440
14. Beltrame J.F., Sasayama S., and Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 6 (1999) 1442-1452
15. Pristipino C., Beltrame J.F., Finocchiaro M.L., Hattori R., Fujita M., Mongiardo R., et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation 101 10 (2000) 1102-1108
16. Baba S., Ozawa H., Sakai Y., Terao A., Konishi M., and Tatara K. Heart disease deaths in a Japanese urban area evaluated by clinical and police records. Circulation 89 1 (1994) 109-115
17. Kawano H., and Ogawa H. Endothelial function and coronary spastic angina. Intern Med 44 2 (2005) 91-99
18. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther 8 4 (1994) 601-610
19. Egashira K., Katsuda Y., Mohri M., Kuga T., Tagawa T., Shimokawa H., et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol 27 6 (1996) 1444-1449
20. Kugiyama K., Murohara T., Yasue H., Kimura T., Sakaino N., Ohgushi M., et al. Increased constrictor response to acetylcholine of the isolated coronary arteries from patients with variant angina. Int J Cardiol 52 3 (1995) 223-233
21. Egashira K., Inou T., Yamada A., Hirooka Y., and Takeshita A. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest 89 3 (1992) 1047-1052
22. Egashira K., Katsuda Y., Mohri M., Kuga T., Tagawa T., Shimokawa H., et al. Links Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol 27 6 (1996) 1444-1449
23. Somlyo A.P., and Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature 372 6503 (1994) 231-236
24. Shimokawa H., Seto M., Katsumata N., Amano M., Kozai T., Yamawaki T., et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 43 4 (1999) 1029-1039
25. Kandabashi T., Shimokawa H., Miyata K., Kunihiro I., Kawano Y., Fukata Y., et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1 beta. Circulation 101 11 (2000) 1319-1323
26. Masumoto A., Mohri M., Shimokawa H., Urakami L., Usui M., and Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105 13 (2002) 1545-1547
27. Pollock D.M., and Pollock J.S. Endothelin and oxidative stress in the vascular system. Curr Vasc Pharmacol 3 4 (2005) 365-367
28. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 10 (2000) 840-844
29. Matsubara T., Nakazawa M., Yoshida Y., Imai S., Suzuki K., Hori T., et al. Increasing vasoconstrictor response to ergonovine with oxidative injury in canine coronary artery. Coron Artery Dis 8 1 (1997) 1-7
30. Murohara T., Kugiyama K., Ohgushi M., Sugiyama S., and Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 266 3 Pt 2 (1994) H874-H880
31. Morrow J.D., Frei B., Longmire A.W., Gaziano J.M., Lynch S.M., Shyr Y., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332 18 (1995) 1198-1203
32. Sugiishi M., and Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 87 1 (1993) 76-79
33. Motoyama T., Kawano H., Kugiyama K., Hirashima O., Ohgushi M., Tsunoda R., et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 32 6 (1998) 1672-1679
34. Hirashima O., Kawano H., Motoyama T., Hirai N., Ohgushi M., Kugiyama K., et al. Improvement of endothelial function and insulin sensitivity with Vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol 35 7 (2000) 1860-1866
35. Sueda S., Ochi N., Kawada H., Matsuda S., Hayashi Y., Tsuruoka T., et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 83 8 (1999) 1186-1190
36. Yasue H., Touyama M., Shimamoto M., Kato H., and Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 50 3 (1974) 534-539
37. Bertrand M.E., Lablanche J.M., Tilmant P.Y., Ducloux G., Warembourg Jr. H., and Soots G. Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. Am J Cardiol 47 6 (1981) 1375-1378
38. Winniford M.D., Filipchuk N., and Hillis L.D. Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial. Circulation 67 6 (1983) 1185-1188
39. Robertson R.M., Bernard Y.D., Carr R.K., and Robertson D. Alpha-adrenergic blockade in vasotonic angina: lack of efficacy of specific alpha 1-receptor blockade with prazosin. J Am Coll Cardiol 2 6 (1983) 1146-1150
40. Chang K., Baek S.H., Seung K.B., Kim P.J., Ihm S.H., Chae J.S., et al. The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis 14 4 (2003) 293-299
41. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Ogawa H., Kugiyama K., et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786 → C and missense Glu298Asp variants. J Investig Med 48 5 (2000) 367-374
42. Ito T., Yasue H., Yoshimura M., Nakamura S., Nakayama M., Shimasaki Y., et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 110 1 (2002) 89-94
43. Horimoto M., Wakisaka A., Takenaka T., Igarashi K., Inoue H., Yoshimura H., et al. Familial evidence of vasospastic angina and possible involvement of HLA-DR2 in susceptibility to coronary spasm. Jpn Circ J 62 4 (1998) 284-288
44. Nakao K., Ohgushi M., Yoshimura M., Morooka K., Okumura K., Ogawa H., et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 80 5 (1997) 545-549
45. Sueda S., Kohno H., Fukuda H., Ochi N., Kawada H., Hayashi Y., et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 15 8 (2004) 491-497
46. Kaski J.C., Crea F., Meran D., Rodriguez L., Araujo L., Chierchia S., et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 74 6 (1986) 1255-1265
47. Scanlon P.J., Faxon D.P., Audet A.M., Carabello B., Dehmer G.J., Eagle K.A., et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33 6 (1999) 1756-1824
48. Sueda S., Izoe Y., Kohno H., Fukuda H., and Uraoka T. Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan. Circ J 69 11 (2005) 1333-1337
49. Buxton A., Goldberg S., Hirshfeld J.W., Wilson J., Mann T., Williams D.O., et al. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol 46 2 (1980) 329-334
50. Sueda S., Saeki H., Otani T., Mineoi K., Kondou T., Yano K., et al. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. Am J Cardiol 85 3 (2000) 391-394
51. Adlam D., Azeem T., Ali T., and Gershlick A. Is there a role for provocation testing to diagnose coronary artery spasm?. Int J Cardiol 102 1 (2005) 1-7
52. Hamilton K.K., and Pepine C.J. A renaissance of provocative testing for coronary spasm?. J Am Coll Cardiol 35 7 (2000) 1857-1859
53. Miwa K., Fujita M., and Miyagi Y. Beneficial effects of smoking cessation on the short-term prognosis for variant angina-validation of the smoking status by urinary cotinine measurements. Int J Cardiol 44 2 (1994) 151-156
54. Freedman S.B., Richmond D.R., and Kelly D.T. Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am J Cardiol 50 4 (1982) 711-715
55. Ardissino D., Savonitto S., Mussini A., Zanini P., Rolla A., Barberis P., et al. Felodipine (once daily) versus nifedipine (four times daily) for Prinzmetal's angina pectoris. Am J Cardiol 68 17 (1991) 1587-1592
56. Satake K., Lee J.D., Shimizu H., Ueda T., and Nakamura T. Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina. J Am Coll Cardiol 28 4 (1996) 897-902
57. Miyagi H., Yasue H., Okumura K., Ogawa H., Goto K., and Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 79 3 (1989) 597-602
58. Chen J.W., Hsu N.W., Wu T.C., Lin S.J., and Chang M.S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90 9 (2002) 974-982
59. Sueda S., Kohno H., Fukuda H., Watanabe K., Ochi N., Kawada H., et al. Limitations of medical therapy in patients with pure coronary spastic angina. Chest 123 2 (2003) 380-386
60. Bory M., Pierron F., Panagides D., Bonnet J.L., Yvorra S., and Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 17 7 (1996) 1015-1021
61. Khatri S., Webb J.G., Carere R.G., and Dodek A. Stenting for coronary artery spasm. Catheter Cardiovasc Interv 56 1 (2002) 16-20
62. Gaspardone A., Tomai F., Versaci F., Ghini A.S., Polisca P., Crea F., et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol 84 1 (1999) 96-98
63. Tanabe Y., Itoh E., Suzuki K., Ito M., Hosaka Y., Nakagawa I., et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol 39 7 (2002) 1120-1126
64. Robertson R.M., Wood A.J., Vaughn W.K., and Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 65 2 (1982) 281-285
65. Turlapaty P.D., and Altura B.M. Propranolol induces contractions of canine small and large coronary arteries. Basic Res Cardiol 77 1 (1982) 68-81
66. Tilmant P.Y., Lablanche J.M., Thieuleux F.A., Dupuis B.A., and Bertrand M.E. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol 52 3 (1983) 230-233
67. Miwa K., Kambara H., and Kawai C. Effect of aspirin in large doses on attacks of variant angina. Am Heart J 105 2 (1983) 351-355
68. Yasue H., Takizawa A., Nagao M., Nishida S., Horie M., Kubota J., et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 78 1 (1988) 1-9
69. Walling A., Waters D.D., Miller D.D., Roy D., Pelletier G.B., and Theroux P. Long-term prognosis of patients with variant angina. Circulation 76 5 (1987) 990-997
70. Shimokawa H., Nagasawa K., Irie T., Egashira S., Egashira K., Sagara T., et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol 18 3 (1988) 331-349
71. Pasceri V., Lanza G.A., Patti G., Pedrotti P., Crea F., and Maseri A. Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina. Circulation 94 8 (1996) 1850-1856
72. Friedman A.C., Spindola-Franco H., and Nivatpumin T. Coronary spasm: Prinzmetal's variant angina versus catheter-induced spasm; refractory spasm versus fixed stenosis. AJR Am J Roentgenol 132 6 (1979) 897-904
73. Fischell T.A., Derby G., Tse T.M., and Stadius M.L. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. Circulation 78 6 (1988) 1323-1334
74. Moukarbel G.V., and Dakik H.A. Diffuse coronary artery spasm induced by guidewire insertion. J Invasive Cardiol 15 6 (2003) 353-354
75. Gruberg L., and Waksman R. Severe acute coronary spasm following intracoronary radiation for in-stent restenosis: a case report. Cardiovasc Radiat Med 2 3 (2001) 138-142
76. el-Tamimi H., Davies G.J., Crea F., and Maseri A. Response of human coronary arteries to acetylcholine after injury by coronary angioplasty. J Am Coll Cardiol 21 5 (1993) 1152-1157
77. Lange R.A., Cigarroa R.G., Yancy Jr. C.W., Willard J.E., Popma J.J., Sills M.N., et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 321 23 (1989) 1557-1562
78. Mo W., Singh A.K., Arruda J.A., and Dunea G. Role of nitric oxide in cocaine-induced acute hypertension. Am J Hypertens 11 6 Pt 1 (1998) 708-714
79. Nakamura Y., Shinozaki N., Hirasawa M., Kato R., Shiraishi K., Kida H., et al. Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Jpn Circ J 64 4 (2000) 239-242
80. Murakami H., Hirokami M., Hanawa N., Oomoto Y., Yamaguchi Y., Miyamoto K., et al. Acetylcholine-induced coronary spasm with a history of Kawasaki disease: case report. Circ J 67 3 (2003) 273-274
81. Petrakopoulou P., Franz W.M., Boekstegers P., and Weis M. Vasospastic angina pectoris associated with Churg-Strauss syndrome. Nat Clin Pract Cardiovasc Med 2 9 (2005) 484-489